631 related articles for article (PubMed ID: 7694306)
21. Risperidone in the treatment of chronic schizophrenic patients: an international double-blind parallel-group study versus haloperidol. The International Risperidone Research Group.
Müller-Spahn F
Clin Neuropharmacol; 1992; 15 Suppl 1 Pt A():90A-91A. PubMed ID: 1379882
[No Abstract] [Full Text] [Related]
22. New drug offers hope for people with schizophrenia.
J Psychosoc Nurs Ment Health Serv; 1994 May; 32(5):46. PubMed ID: 7519676
[No Abstract] [Full Text] [Related]
23. Olanzapine versus haloperidol in the treatment of schizophrenia and schizoaffective and schizophreniform disorders: results of an international collaborative trial.
Tollefson GD; Beasley CM; Tran PV; Street JS; Krueger JA; Tamura RN; Graffeo KA; Thieme ME
Am J Psychiatry; 1997 Apr; 154(4):457-65. PubMed ID: 9090331
[TBL] [Abstract][Full Text] [Related]
24. Antipsychotic medication in the treatment of schizophrenia.
Kane JM
Isr J Psychiatry Relat Sci; 1995; 32(1):30-7. PubMed ID: 7542642
[TBL] [Abstract][Full Text] [Related]
25. Changes in single symptoms and separate factors of the schizophrenic syndrome after treatment with risperidone or haloperidol.
Lindström E; von Knorring L
Pharmacopsychiatry; 1994 May; 27(3):108-13. PubMed ID: 7521534
[TBL] [Abstract][Full Text] [Related]
26. An open, randomized, comparative study of efficacy and safety of risperidone and haloperidol in schizophrenia.
Tamrakar SM; Nepal MK; Koirala NR; Sharma VD; Gurung CK; Adhikari SR
Kathmandu Univ Med J (KUMJ); 2006; 4(2):152-60. PubMed ID: 18603890
[TBL] [Abstract][Full Text] [Related]
27. Risperidone in the treatment of disorders with a combined psychotic and depressive syndrome--a functional approach.
Hillert A; Maier W; Wetzel H; Benkert O
Pharmacopsychiatry; 1992 Sep; 25(5):213-7. PubMed ID: 1384075
[TBL] [Abstract][Full Text] [Related]
28. Risperidone versus haloperidol in the treatment of chronic schizophrenic inpatients: a multicentre double-blind comparative study.
Claus A; Bollen J; De Cuyper H; Eneman M; Malfroid M; Peuskens J; Heylen S
Acta Psychiatr Scand; 1992 Apr; 85(4):295-305. PubMed ID: 1375801
[TBL] [Abstract][Full Text] [Related]
29. Cis(Z)-clopenthixol and haloperidol in chronic schizophrenic patients--a double-blind clinical multicentre investigation.
Heikkilä L; Laitinen J; Vartiainen H
Acta Psychiatr Scand Suppl; 1981; 294():30-8. PubMed ID: 7041517
[TBL] [Abstract][Full Text] [Related]
30. Risperidone and haloperidol in first-episode psychosis: a long-term randomized trial.
Schooler N; Rabinowitz J; Davidson M; Emsley R; Harvey PD; Kopala L; McGorry PD; Van Hove I; Eerdekens M; Swyzen W; De Smedt G;
Am J Psychiatry; 2005 May; 162(5):947-53. PubMed ID: 15863797
[TBL] [Abstract][Full Text] [Related]
31. Efficacy of risperidone on positive features of schizophrenia.
McEvoy JP
J Clin Psychiatry; 1994 May; 55 Suppl():18-21. PubMed ID: 7520904
[TBL] [Abstract][Full Text] [Related]
32. Desmopressin for risperidone-induced enuresis.
Bennett JA; Keck PE; Wallhausser LJ
Ann Clin Psychiatry; 1994 Jun; 6(2):139-40. PubMed ID: 7528602
[No Abstract] [Full Text] [Related]
33. The acute efficacy of aripiprazole across the symptom spectrum of schizophrenia: a pooled post hoc analysis from 5 short-term studies.
Janicak PG; Glick ID; Marder SR; Crandall DT; McQuade RD; Marcus RN; Eudicone JM; Assunção-Talbott S
J Clin Psychiatry; 2009 Jan; 70(1):25-35. PubMed ID: 19192472
[TBL] [Abstract][Full Text] [Related]
34. Risperidone versus haloperidol in the treatment of chronic schizophrenic patients: a parallel group double-blind comparative trial.
Min SK; Rhee CS; Kim CE; Kang DY
Yonsei Med J; 1993 Jun; 34(2):179-90. PubMed ID: 7691017
[TBL] [Abstract][Full Text] [Related]
35. Risperidone in the treatment of patients with chronic schizophrenia: a multi-national, multi-centre, double-blind, parallel-group study versus haloperidol. Risperidone Study Group.
Peuskens J
Br J Psychiatry; 1995 Jun; 166(6):712-26; discussion 727-33. PubMed ID: 7545060
[TBL] [Abstract][Full Text] [Related]
36. [Double-blind comparison of 3 x 75 mg zotepine und 3 x 4 mg haloperidol in acute schizophrenic patients].
Klieser E; Lehmann E; Tegeler J
Fortschr Neurol Psychiatr; 1991 Sep; 59 Suppl 1():14-7. PubMed ID: 1683333
[TBL] [Abstract][Full Text] [Related]
37. Depressive symptoms and their association with acute treatment outcome in first-episode schizophrenia patients: comparing treatment with risperidone and haloperidol.
Riedel M; Mayr A; Seemüller F; Maier W; Klingberg S; Heuser I; Klosterkötter J; Gastpar M; Schmitt A; Sauer H; Schneider F; Gaebel W; Jäger M; Möller HJ; Schennach-Wolff R
World J Biol Psychiatry; 2012 Jan; 13(1):30-8. PubMed ID: 21568628
[TBL] [Abstract][Full Text] [Related]
38. Negative signs and symptoms secondary to antipsychotics: a double-blind, randomized trial of a single dose of placebo, haloperidol, and risperidone in healthy volunteers.
Artaloytia JF; Arango C; Lahti A; Sanz J; Pascual A; Cubero P; Prieto D; Palomo T
Am J Psychiatry; 2006 Mar; 163(3):488-93. PubMed ID: 16513871
[TBL] [Abstract][Full Text] [Related]
39. A path-analytical approach to differentiate between direct and indirect drug effects on negative symptoms in schizophrenic patients. A re-evaluation of the North American risperidone study.
Möller HJ; Müller H; Borison RL; Schooler NR; Chouinard G
Eur Arch Psychiatry Clin Neurosci; 1995; 245(1):45-9. PubMed ID: 7540426
[TBL] [Abstract][Full Text] [Related]
40. Clinical review of risperidone.
Chouinard G; Arnott W
Can J Psychiatry; 1993 Sep; 38 Suppl 3():S89-95. PubMed ID: 7504574
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]